Literature DB >> 25998940

Which factors are associated with quality of life in patients with Graves' orbitopathy presenting for orbital decompression surgery?

S Wickwar1, H B McBain2, D G Ezra3, S P Hirani4, G E Rose3, S P Newman4.   

Abstract

PURPOSE: Graves' orbitopathy (GO) is associated with changes in the appearance of the eyes and visual dysfunction. Patients report feeling socially isolated and unable to continue with day-to-day activities. This study aimed at investigating the demographic, clinical, and psychosocial factors associated with quality of life in patients presenting for orbital decompression surgery.
METHODS: One-hundred and twenty-three adults with GO due for orbital decompression at Moorfields Eye Hospital London were recruited prospectively. Clinical measures including treatment history, exophthalmos, optic neuropathy, and diplopia were taken by an ophthalmologist. Participants completed psychosocial questionnaires, including the Graves' Ophthalmopathy Quality of Life Scale (GO-QOL), the Hospital Anxiety and Depression Scale, and the Derriford Appearance Scale. Hierarchical multiple regression analyses were used to identify predictors of quality of life.
RESULTS: Higher levels of potential cases of clinical anxiety (37%) and depression (26%) were found in this study sample than in patients with other chronic diseases or facial disfigurements. A total of 55% of the variance in GO-QOL visual function scores was explained by the regression model; age, asymmetrical GO and depressed mood were significant unique contributors. In all, 75% of the variance in GO-QOL appearance scores was explained by the regression model; gender, appearance-related cognitions and depressed mood were significant unique contributors.
CONCLUSION: Appearance-related quality of life and mood were particularly affected in this sample. Predominantly psychosocial characteristics were associated with quality of life. It is important when planning surgery for patients that clinicians be aware of factors that could potentially influence outcomes.

Entities:  

Mesh:

Year:  2015        PMID: 25998940      PMCID: PMC4506351          DOI: 10.1038/eye.2015.76

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  22 in total

1.  Individual differences in social comparison: development of a scale of social comparison orientation.

Authors:  F X Gibbons; B P Buunk
Journal:  J Pers Soc Psychol       Date:  1999-01

2.  Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy.

Authors:  M P Mourits; M F Prummel; W M Wiersinga; L Koornneef
Journal:  Clin Endocrinol (Oxf)       Date:  1997-07       Impact factor: 3.478

Review 3.  Pathogenesis of Graves' ophthalmopathy.

Authors:  R S Bahn; A E Heufelder
Journal:  N Engl J Med       Date:  1993-11-11       Impact factor: 91.245

4.  Factors associated with quality of life and mood in adults with strabismus.

Authors:  Hayley B McBain; Kelly A MacKenzie; Charis Au; Joanne Hancox; Daniel G Ezra; Gillian G W Adams; Stanton P Newman
Journal:  Br J Ophthalmol       Date:  2014-01-03       Impact factor: 4.638

5.  Quality of life in patients with Graves' ophthalmopathy is markedly decreased: measurement by the medical outcomes study instrument.

Authors:  M N Gerding; C B Terwee; F W Dekker; L Koornneef; M F Prummel; W M Wiersinga
Journal:  Thyroid       Date:  1997-12       Impact factor: 6.568

6.  Psychosocial factors in subjects with thyroid-associated ophthalmopathy.

Authors:  George J Kahaly; Jochen Hardt; Frank Petrak; Ulrich T Egle
Journal:  Thyroid       Date:  2002-03       Impact factor: 6.568

7.  Altered body image: appearance-related concerns of people with visible disfigurement.

Authors:  Nichola Rumsey; Alex Clarke; Paul White; Menna Wyn-Williams; Wendy Garlick
Journal:  J Adv Nurs       Date:  2004-12       Impact factor: 3.187

8.  Exploring the psychosocial concerns of outpatients with disfiguring conditions.

Authors:  N Rumsey; A Clarke; P White
Journal:  J Wound Care       Date:  2003-07       Impact factor: 2.072

9.  The hospital anxiety and depression scale.

Authors:  A S Zigmond; R P Snaith
Journal:  Acta Psychiatr Scand       Date:  1983-06       Impact factor: 6.392

10.  Assessing quality of life in Australian patients with Graves' ophthalmopathy.

Authors:  J J Park; T J Sullivan; R H Mortimer; M Wagenaar; D A Perry-Keene
Journal:  Br J Ophthalmol       Date:  2004-01       Impact factor: 4.638

View more
  7 in total

Review 1.  Orbital Decompression for Thyroid Eye Disease.

Authors:  Tara L Braun; Mohin A Bhadkamkar; Kevin T Jubbal; Adam C Weber; Douglas P Marx
Journal:  Semin Plast Surg       Date:  2017-02       Impact factor: 2.314

2.  Predictive Factors of Development of Graves' Ophthalmopathy for Patients with Juvenile Graves' Disease.

Authors:  Dalia Jarusaitiene; Rasa Verkauskiene; Vytautas Jasinskas; Jurate Jankauskiene
Journal:  Int J Endocrinol       Date:  2016-06-16       Impact factor: 3.257

3.  Prevalence and severity of ocular involvement in Graves' disease according to sex and age: A clinical study from Babol, Iran.

Authors:  Sara Gharib; Zoleika Moazezi; Mohammad Ali Bayani
Journal:  Caspian J Intern Med       Date:  2018

4.  Disrupted Topological Organization of the Brain Structural Network in Patients With Thyroid-Associated Ophthalmopathy.

Authors:  Qian Wu; Hao Hu; Wen Chen; Huan-Huan Chen; Lu Chen; Jiang Zhou; Hu Liu; Fei-Yun Wu; Xiao-Quan Xu
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-04-01       Impact factor: 4.799

5.  Altered Static and Dynamic Interhemispheric Resting-State Functional Connectivity in Patients With Thyroid-Associated Ophthalmopathy.

Authors:  Wen Chen; Hao Hu; Qian Wu; Lu Chen; Jiang Zhou; Huan-Huan Chen; Xiao-Quan Xu; Fei-Yun Wu
Journal:  Front Neurosci       Date:  2021-12-06       Impact factor: 4.677

6.  Improvement of asymmetric thyroid eye disease with teprotumumab.

Authors:  Shoaib Ugradar; Yao Wang; Tunde Mester; George J Kahaly; Raymond Douglas
Journal:  Br J Ophthalmol       Date:  2021-02-12       Impact factor: 5.908

7.  Disrupted Spontaneous Neural Activity in Patients With Thyroid-Associated Ophthalmopathy: A Resting-State fMRI Study Using Amplitude of Low-Frequency Fluctuation.

Authors:  Wen Chen; Qian Wu; Lu Chen; Jiang Zhou; Huan-Huan Chen; Xiao-Quan Xu; Hao Hu; Fei-Yun Wu
Journal:  Front Hum Neurosci       Date:  2021-06-11       Impact factor: 3.169

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.